Literature DB >> 14628338

[Efficacy of naphthoquine, artemisinine and a combination of the two drugs in the treatment of falciparum malaria].

Jing-yan Wang1, Cheng-qi Shan, Da-dong Fu, Zhi-wei Sun, De-ben Ding.   

Abstract

OBJECTIVE: To compare the efficacy and safety of naphthoquine, artemisinine and a combination of the two drugs in the treatment of faciparum malaria.
METHODS: Of 230 patients, 100 patients were treated with combined regime (Co-NQ), 100 patients were treated with naphthoquine (NQ) and 30 patients were treated with artemisinine (QHS). All patients were hospitalized for 7 days and followed up for 28 days.
RESULTS: The mean fever clearance time for Co-NQ, NQ, and QHS was (17.5 +/- 12.3)h, (32.7 +/- 17.7)h and (18.1 +/- 9.7)h respectively; the mean parasite clearance time was (30.0 +/- 8.8)h, (45.5 +/- 10.0)h and (29.1 +/- 6.0)h respectively; and the 28 days cure rate was 97.0%, 100.0% and 66.7% respectively.
CONCLUSION: The Co-NQ possesses benefits of both naphthoquine and artemisinine, acting rapidly, with a short course of only one dose and a high cure rate. The regime is well tolerated by patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14628338

Source DB:  PubMed          Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi        ISSN: 1000-7423


  9 in total

1.  Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria.

Authors:  Nicholas J White; Tran T Duong; Chirapong Uthaisin; François Nosten; Aung P Phyo; Borimas Hanboonkunupakarn; Sasithon Pukrittayakamee; Podjanee Jittamala; Kittiphum Chuthasmit; Ming S Cheung; Yiyan Feng; Ruobing Li; Baldur Magnusson; Marc Sultan; Daniela Wieser; Xiaolei Xun; Rong Zhao; Thierry T Diagana; Peter Pertel; F Joel Leong
Journal:  N Engl J Med       Date:  2016-09-22       Impact factor: 91.245

Review 2.  Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy.

Authors:  Brioni R Moore; Moses Laman; Sam Salman; Kevin T Batty; Madhu Page-Sharp; Francis Hombhanje; Laurens Manning; Timothy M E Davis
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

3.  Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in Indonesia.

Authors:  Emiliana Tjitra; Armedy R Hasugian; Hadjar Siswantoro; Budi Prasetyorini; Riyanti Ekowatiningsih; Endah A Yusnita; Telly Purnamasari; Srilaning Driyah; Ervi Salwati; Eni Yuwarni; Lidwina Januar; Joseph Labora; Bambang Wijayanto; Fajar Amansyah; Tersila A D Dedang; Asep Purnama
Journal:  Malar J       Date:  2012-06-14       Impact factor: 2.979

4.  Open-label trial of three dosage regimens of fixed-dose combination of artemisinin and naphthoquine for treating uncomplicated falciparum malaria in Calabar, Nigeria.

Authors:  Martin M Meremikwu; Friday Odey; Chioma Oringanje; Angela Oyo-Ita; Emmanuel Effa; Ekpereonne B Esu; Eyam Eyam; Olabisi Oduwole; Vivian Asiegbu; Ambrose Alaribe; Emmanuel N Ezedinachi
Journal:  Malar J       Date:  2012-12-11       Impact factor: 2.979

Review 5.  Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria.

Authors:  Rachel Isba; Babalwa Zani; Michael Gathu; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2015-02-23

6.  Development of antimalarial drugs and their application in China: a historical review.

Authors:  Chang Chen
Journal:  Infect Dis Poverty       Date:  2014-03-20       Impact factor: 4.520

7.  Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.

Authors:  Francis W Hombhanje; David Linge; Adolf Saweri; Cynthia Kuanch; Robert Jones; Stephen Toraso; Jacobed Geita; Andrew Masta; Isi Kevau; Gilbert Hiawalyer; Mathias Sapuri
Journal:  Malar J       Date:  2009-08-12       Impact factor: 2.979

Review 8.  A systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malaria.

Authors:  Cho Naing; Maxine A Whittaker; Joon Wah Mak; Kyan Aung
Journal:  Malar J       Date:  2015-10-06       Impact factor: 2.979

9.  Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China.

Authors:  Hui Liu; Heng-lin Yang; Jian-wei Xu; Jia-zhi Wang; Ren-hua Nie; Chun-fu Li
Journal:  Malar J       Date:  2013-11-11       Impact factor: 2.979

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.